Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Geriatrics

Volume 10 Supplement 1

de Senectute: Age and Health Forum

Open Access

Ageing and head and neck cancer

  • E Allegra1
BMC Geriatrics201010(Suppl 1):L3

https://doi.org/10.1186/1471-2318-10-S1-L3

Published: 19 May 2010

In the last decades head and neck cancer incidence has risen in the elderly (>70 years) as a consequence of the increased average lifespan.

Two main mechanisms have been suggested to explain the increase in cancer incidence with ageing: the first refers to prolonged exposure to carcinogens during life and the second explanation seems to be attributed to the individual vulnerability to cancer with age.

To suppress the development of cancer two main strategies are involved: one uses Caretaker proteins to protect genome from mutations and the other uses Gatekeeper proteins to eliminate or prevent the growth of mutated cells.

Recently studies on ageing have shown a correlation between ageing and an increase in the mitochondrial production of Reactive Oxigen Species (ROS) and between mitochondrial function decline age –associate and mitochondrial DNA (mtDNA) mutations.

Mitochondrial DNA mutations have been found to be implicated in the head and neck cancer multistep process.

So, future strategies that prevent mtDNA damage or improve DNA-repair mechanisms are likely to decrease susceptibility to cancer with age.

Authors’ Affiliations

(1)
Department of Otolaryngology-Head and Neck Surgery, University of Catanzaro

Copyright

© Allegra; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Advertisement